POSTER SESSIONS ABSTRACTS
Poster Session V (A)
P-5A
PHARMACOLOGY OF THE NERVOUS SYSTEM (PART 1)
P-5/1 | Demonstrating peripheral
restriction of novel cannabinoid CB1 antagonist TM38837 by evaluating for
expression of conditioned fear in mice V. Micale, PK. Nørregaard, CT. Wotjak (Munich, Hørsholm) |
P-5/2 | Effects of gestational all-trans retinoic acid treatment on the
complex I of mitochondrial respiratory chain in the rat cerebellum D. Signorile, N. Sardaro , D. De Rasmo, S. Papa, P. Borracci, MR. Carratù ( Bari) |
P-5/3 | F3/Contactin gene knockdown results in upregulation of the
dopaminergic phenotype in the basal ganglia A. Massaro, A. Bizzoca, P. Corsi, M. Pinto, M. Persichella, A. Giustino, G. Gennarini, MR. Carratù (Bari) |
P-5/4 | Role of functional polymorphisms
and haplotypes of the serotonin transporter gene in Medication Overuse
Headache S. Terrazzino, C. Tassorelli, G. Sances , M. Viana, G. Nappi, PL. Canonico, AA. Genazzani (Novara, Pavia) |
P-5/5 | Neuroprotective and antiamyloidogenic
effect of Substance P by activation of α -secretase-mediated amyloid precursor
protein cleavage R. Marolda, C. Petrella, MT. Ciotti, R. Possenti, P. Calissano, C. Severini ( Roma) |
P-5/6 | Chronic caffeine intake reduces
the survival in a mice model of amyotrophic lateral sclerosis. R.L. Potenza, A. Ferrante, M. Armida , A. Pezzola, A. Matteucci, P. Popoli (Roma) |
P-5/7 | Understanding β-Amyloid-induced toxicity by a
chemical-biology approach. M. Camarri, L. Terzuoli , T. Ferraro, G. Pollio, D. Diamanti, L. Magnoni, S. Bernocco, C. Scali, S. Rasmussen, HB. Nielsen, AR. Bilia, A. Karioti, L. Millucci, A. Caricasole, D. Franceschini (Siena, Lyngby, Firenze) |
P-5/8 | Viral vector delivery of mutant
huntingtin as model of huntington's disease in the rat: in vivo and in vitro
study. C. Scali, I. Ceccarelli, R. Remelli, D. Franceschini, L. Rossini , G. Pollio, M. Camarri, I. Biotti, A. Cappelli, V. Miragliotta, P. Fiengo, A. Caricasole, G. Gaviraghi (Siena) |
P-5/9 | RANTES-glutamate
interaction in Central Nervous System: a glial to neuron cross-talk relevant
to central neuroinflammation S. Di Prisco , M. Summa, V. Chellakudam, A. Pittaluga (Genova) |
P-5/10 | Salviae neoclerodane derivatives
differently affect catecholamine release in mammals brains: comparison with Salvinorin A. G. Olivero, S. Di Prisco, M. Summa , E. Giacomelli, M. Grilli, A. Bisio, G. Romussi, M. Marchi, A. Pittaluga (Genova) |
P-5/11 | Selective blockade of mGlu5
metabotropic glutamate receptors is protective against hepatic mitochondrial
dysfunction in 6-OHDA lesioned parkinsonian rats A. Ferrigno, MT. Armentero, V. Rizzo, A. Bianchi, G. Ambrosi , P. Richelmi , F. Blandini , M. Vairetti ( Pavia) |
P-5/12 | Adult neural stem cells prevent L-dopa and dopamine autoxidation in
vitro G. Calia, V. Mazzarello, S. Dedola, G. Bazzu, R. Migheli, P.A. Serra, M.S. Desole, G. Rocchitta (Sassari) |
P-5/13 | The new FAAH inhibitorST4070 (1-biphenyl-4-ylethenyl
piperidine-1-carboxilate)reduced anxiety-like behavior in the elevated plus
maze in young male rats S. Di Serio, V. Dainese, D. Guaraldi, M.G. Scrocco , A. Caprioli , F. Borsini (Pomezia - Roma) |
P-5/14 | Natural-like curcumin derivatives protect PC12 cells against Mn,
MPP+ and H2O2 damage S. Dedola, D. Fabbri, M.A. Dettori, G. Delogu, P. Ruzza, P.A. Serra, M.S. Desole, R. Migheli (Sassari) |
P-5/15 | Dual asymmetric-flow microdialysis for monitoring the effects of
MPTP and d-amphetamine on striatal dopamine and energy metabolism in freely moving rats G. Bazzu, G. Calia, G. Rocchitta, R. Migheli, M.S. Desole, P.A. Serra (Sassari) |
P-5/16 | Palmitoylethanolamide
exerts neuroprotective actions in a murine model of
Parkinson's disease E. Esposito, E. Mazzon, I. Paterniti, S. Cuzzocrea (Messina) |
P-5/17 | Role of dorsal
medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat
food seeking induced by the anxiogenic drug yohimbine C. Cifani, B.M. Navarre, S.G. Nair, C.L. Pickens , J.M. Bossert, Y. Shaham (Baltimore, USA) |
P-5/18 | Effect of
neuropeptide S receptor antagonists and partial agonists on highly palatable
food consumption in rats C. Cifani, M.V. Micioni Di B, N. Cannella, M. Ubaldi, R. Guerrini , G. Calò, M. Massi, R. Ciccocioppo (Camerino (MC), Ferrara) |
P-5/19 | Cycles of food
restriction increase the orexigenic effect of Nociceptin/Orphanin FQ (N/OFQ)
and Neuropeptide Y (NPY) in female rats C. Cifani, M.V. Micioni Di B, M. Ubaldi, R. Ciccocioppo, M. Massi (Camerino (MC)) |
P-5/20 | Effect of the
orexin receptors antagonists in a model of binge
eating in female rats M.V. Micioni Di Bonaventura, C. Cifani, M. Corsi, D. Montanari, R. Ciccocioppo, M. Massi, E. Merlo-Pich, L. Piccoli (Camerino (MC), Verona) |
P-5/21 | Effect of salidroside, active principle of Rhodiola rosea
extract, on binge eating C. Cifani, M.V. Micioni Di B, G. Vitale , V. Ruggieri, R. Ciccocioppo, M. Massi (Camerino (MC), Modena) |
P-5/22 | Differential changes in CB1
receptor expression and regulation of GABAergic and glutamatergic functions
in the striatum of Huntington’s disease mice. V. Chiodi, L. Ferraro, M. Uchigashima, A. Martire, S. Beggiato, M. Armida, A. Ferrante, R.L. Potenza, M. Watanabe, S. Tanganelli, M.R. Domenici, P. Popoli (Roma, Ferrara, Sapporo (Japan)) |
P-5/23 | Effect of
gender and age on risperidone plasma concentrations
in pediatric patients with psychotic disorders C. D'Arrigo, V. Santoro, A. Gagliano, E. Germanò, R. Siracusano, E. Spina (Messina) |
P-5/24 | Low-frequency rTMS regulates
emotional behaviour and dendritic plasticity in dentate gyrus R. Crupi, M. Cambiaghi, R. Hen, E. Spina, F. Battaglia ( Messina, Milano, New York) |
P-5/25 | Electrophysiological effects of CHF5074 on rat hippocampus:
protection against in vitro OGD D. Mango, M.B. Panico, V. Porrini , I. Sarnico, M. Pizzi, B.P. Imbimbo , N.B. Mercuri , R. Nisticò (Roma, Brescia, Parma, Roma, Arcavacata di Rende) |
P-5/26 | A microfluidic
device for investigating biomolecular cascades between different CNS cell
populations N. Tonna, F. Bianco , R. Lovchik, E. Delamarche, M. Matteoli (Milano, Ruschlikon) |
P-5/27 | Predictive role of the scavenger receptor CD36 in course of
neurodegeneration in APP23 mice M. Giunta, M. Morbin, G. Giaccone, S.M. Bonomo, A.E. Rigamonti, S.G. Cella (Milano) |
P-5/28 | Molecular mechanisms underlying melanocortin-induced neurogenesis
following ischemic stroke L. Spaccapelo, M. Galantucci, A. Ottani, M. Contri, F. Cavallini, D. Zaffe, D. Giuliani, S. Guarini (Modena) |
P-5/29 | Direct evidence that melanocortin MC4 receptor
stimulation induces neuroprotection against ischemic stroke A. Ottani, A. Bitto, L. Spaccapelo, M. Galantucci, L. Minutoli, D. Altavilla, E. Novellino, P. Grieco, D. Zaffe, F. Squadrito, D. Giuliani, S. Guarini (Modena, Messina, Napoli) |
P-5/30 | Excessive and
precocious glutamate release in the spinal cord of a mouse model of
amyotrophic lateral sclerosis T. Bonifacino, M. Milanese, F. Onofri , L. Musazzi, D. Tardito, M. Messa, C. Usai, G. Racagni, F. Benfenati, M. Popoli, G. Bonanno (Genova, Milano, New Haven) |
P-5/31 | Intravenous mesenchymal stem cells improve survival and motor
functions in symptomatic mutant SOD1/G93A mice M. Milanese, T. Bonifacino, F. Giribaldi, M.C. Principato, S. Morando, S. Casazza, D. Giunti, L. Vergani, E. Carminati, A. Uccelli, A. Voci, G. Bonanno (Genova) |
P-5/32 | Epigenetic modifications in
transgenic mouse with human polymorphism (Val66Met) of BDNF gene S. Corna, A. Mallei, C. Benevento, D. Tardito, G. Racagni, F.S. Lee, M. Popoli (Milano, New York) |
P-5/33 | Reduction of SNAP-25 expression enhances evoked glutamatergic
transmission and induces epileptiform activity associated with memory defects I. Corradini, F. Antonucci, A. Donzelli, S. De Astis, R. Martucci, D. Braida, C. Verderio, M. Sala, M. Matteoli (Milano) |
P-5/34 | Effects of chronic antidepressant
treatments on expression of inflammatory biomarkers in the rat hypothalamus C. Montanari, S. Alboni, C. Benatti, F. Tascedda, N. Brunello ( Modena) |
P-5/35 | Depression and Epilepsy in a
genetic animal model: pharmacology and hippocampal damage. E. Russo, R. Citraro, F. Scicchitano, I. Perrotta, G. Donato, P. De Fazio, G. De Sarro (Catanzaro, Cosenza) |
P-5/36 | Central effects of a local
inflammation on three commonly used mouse strains with a different anxious
phenotype C. Benatti, S. Alboni, C. Montanari, F. Tascedda, N. Brunello, JMC. Blom (Modena) |
P-5/37 | Mesoangioblast-based
supplementation of neurotrophic factors for the treatment of neuronal damage. S. Zucchini, T. Su, A. Binaschi , B. Paradiso, R. Bovolenta , M. Barbieri, R. Scardigli, L. Fasulo , G. Cossu, A. Cattaneo, M. Simonato (Ferrara, Roma, Milano) |
P-5/38 | Preclinical antiepileptic and
antiepileptogenic effects of alpha-lactoalbumin, a whey protein rich in
tryptophan. R. Citraro, S. De Fazio, F. Scicchitano, S. Chimirri, A. Urzino, M. Menniti, R. Marra, G. De Sarro, E. Russo (Catanzaro) |
P-5/39 | Effects of the continuous delivery
of a potent NOP receptor antagonist, [Nphe1, Arg14, Lys15] N/OFQ-NH2 (UFP-101), on molecular, cellular
and behavioral alterations in a chronic model of stress. M. Filaferro, S. Zucchini, V. Ruggieri , G. Vitale, C. Novi , C. Cifani, M. Massi, M. Simonato (Modena, Ferrara, Camerino) |
P-5/40 | Topiramate in
the Treatment of Obesity Induced by Psychotropic Drugs in a Patient with Bipolar Disorder: A Case Report W. Milano, M. De Rosa, L. Milano, G. Nolfe, C. Petrella, A. Capasso (Napoli, Salerno) |
P-5/41 | Serotoninergic or dopaminergic
pathways influence coping behavior in mice after neuroleptics treatment. S. De Fazio, E. Russo, S. Gratteri, M. Aribitrio, G. Trombetta, E. Donato Di Paola, G. De Sarro (Catanzaro, Vibo Valentia) |